Limited Protective Effect of the CCR5Δ32/CCR5Δ32 Genotype on Human Immunodeficiency Virus Infection Incidence in a Cohort of Patients with Hemophilia and Selection for Genotypic X4 Virus

Autor: Jørn Attermann, Arne Svejgaard, Peter Skinhøj, Claus Bohn Christiansen, Sam Schulman, Jørgen Ingerslev, Astrid K. N. Iversen, Erik Berntorp, Jan Gerstoft, Ebbe Dickmeiss, Elma Scheibel, L Tengborn, Lars Fugger, Jesper Eugen-Olsen

Publikováno v: Iversen, A K N, Christiansen, C B, Attermann, J, Eugen-Olsen, J, Schulman, S, Berntop, E, Ingerslev, J, Fugger, L H, Scheibel, E, Tengborn, L, Gerstoft, J, Dickmeiss, E, Svejgaard, A & Skinhøj, P 2003, ' Limited protective effect of the CCR5Δ32/CCR5Δ32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus ', Journal of Infectious Diseases, vol. 187, no. 2, pp. 215-225 . https://doi.org/10.1086/345881
Iversen, A K N, Christiansen, C B, Attermann, J, Eugen-Olsen, J, Schulman, S, Berntorp, E, Ingerslev, J, Fugger, L, Scheibel, E, Tengborn, L, Gerstoft, J, Dickmeiss, E, Svejgaard, A & Skinhøj, P 2003, ' Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus. ', Journal of Infectious Diseases, vol. 187, no. 2, pp. 215-25 .
Iversen, J, Christiansen, C B, Attermann, J, Eugen-Olsen, J, Schulman, S, Berntorp, E, Ingerslev, J, Fugger, L, Scheibel, E, Tengborn, L, Gerstoft, J, Dickmeiss, E, Svejgaard, A & Skinhoj, P 2003, ' Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodificiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus ', J Infect Dis, vol. 2, no. 187, pp. 215-225 .

Udgivelsesdato: 2003-Jan-15 The relationship among CCR5 genotype, cytomegalovirus infection, and disease progression and death was studied among 159 human immunodeficiency virus (HIV)-infected patients with hemophilia. One patient (0.6%) had the CCR5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::938592e779b0700fb814ca41973192b0
https://doi.org/10.1086/345881

APC Resistance and other Haemostatic Variables during Pregnancy and Puerperium

Autor: M. Hellgren, S. Rosén, U. Kjellberg, L. Tengborn, N.-E. Andersson

Publikováno v: Europe PubMed Central

SummaryForty-eight healthy pregnant women were studied prospectively and longitudinally. Blood sampling was performed at 10-15, 23-25, 32-34 and 38-40 weeks of gestation, within one week and at eight weeks postpartum. Classic and modified activated p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e74aed4819338b2d2a31b6c5b4d015
https://doi.org/10.1055/s-0037-1614518

Recombinant, B-domain Deleted Factor VIII (r-VIII SQ): Pharmacokinetics and Initial Safety Aspects in Hemophilia A Patients

Autor: Erik Berntorp, Hans Johnsson, J Spira, C Stahl, G. F. Savidge, Karin Fijnvandraat, J W ten Cate, M. Peters, L Tengborn

Publikováno v: Thrombosis and haemostasis, 77(2), 298-302. Schattauer GmbH

SummaryThe pharmacokinetics of a second-generation recombinant B-domain deleted factor VIII (FVIII) preparation (r-VIII SQ) were studied in 36 patients with severe hemophilia A. In contrast to full-length recombinant FVIII, no albumin needs to be add

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f2c39a8216a5aed0f7b9bfe734bd25f
https://doi.org/10.1055/s-0038-1655957

von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis

Autor: L Tengborn, Bengt-Åke Bengtsson, E Nordborg, Rune Andersson, S Edén

Publikováno v: Annals of the Rheumatic Diseases. 50:316-320

Sixty three patients (51 women, 12 men) with giant cell arteritis were studied by serial analyses of von Willebrand factor antigen (vWF: Ag) concentration and plasminogen activator inhibitor activity. Their mean age at the time of diagnosis was 71 ye

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::455b4f90508f7085b1e163771034d665
https://doi.org/10.1136/ard.50.5.316

Experience with a new percutaneous port system, Percuseal, for intravenous injection in patients with haemophilia, von Willebrand disease and severe alpha1-antitrypsin deficiency

Autor: E, Berntorp, E, Piitulainen, S, Lethagen, E, Mattson, L, Tengborn, T, Mätzsch

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia. 9(2)

We have implanted a new port system (Percuseal) in altogether 13 patients with haemophilia A, B, von Willebrand disease and alpha1-antitrypsin deficiency in order to facilitate venous access. The Percuseal system differs from subcutaneous ports, such

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b236096599aa3eebab785531a2dbf2f4
https://pubmed.ncbi.nlm.nih.gov/12614368